chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nerve conduction studies, Paraesthesia, Paraesthesia oral, Scan with contrast normal, Tongue discomfort
Clinical narrative: ALS symptoms became noticeable 2 weeks after her second Pfizer COVID vaccine shot (March 30, 2021). Here are how her symptoms presented:  End March of 2021 ?Started to feel tingling and numbness in her left hand.   July 2021. ?Went to see Primary Care Manager (PCM) at Facility, but was sent to ER because of high blood pressure related to lab coat fear (I am a retired, and during that time, we used the medical facility).  January 2022 established a new PCM (Not related to installation), because of increased left finger weakness. ?Difficulty holding clipper and clipping right fingernails ?Numbness, reduced dexterity, and mobility ?Referred to Electromyography (EMG) for carpal tunnel syndrome -prognosis negative (PCM suspected pinched nerve). Electromyography (EMG) measures muscle response or electrical activity in response to a nerve's stimulation of the muscle. The test is used to help detect neuromuscular abnormalities.  ?Referred to MRI for neck, and Physical Therapy ?No pinched nerve on MRI ?Physical Therapy had no effects, grip in hand weaker after 1 month   April 28, 2022. After visiting again with a new PCM because her left finger was getting weaker, suggested MRIs. ?MRI of the brain for Parkinson?s Disease -negative. ?MRI Brachial Plexus W/ & W/O Contrast -negative ?Referral to In-Network Neurologist   June 21, 2022. Visit with Dr (Neurologist) ?Blood work ordered ?EMG ordered   August 22, 2022. Visit with Dr for EMG ?Motor Nerve Conduction Studies completed ?Blood work ordered ?B12 High, Asialo-GM1 High    Late Sep 2022  ?left leg weakness and right finger tingling, numbness & weakness.   Mid Oct 2022  ?Slurred speeches on and off  ?Burning tingling sensation on my tongue   Late NOV 2022 Seen by Dr., -Medical Neurology ?EMG Ordered ?Invitae Genetic Testing ?Diagnosed with ALS   Mid-February 2023 Seen by Dr., for second opinion. ?EMG Ordered ?Invitae Genetic Testing ?Prevention Genetics Genetic Testing ?Diagnosed with ALS
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vitamin B12 increased, White coat hypertension
Clinical narrative: ALS symptoms became noticeable 2 weeks after her second Pfizer COVID vaccine shot (March 30, 2021). Here are how her symptoms presented:  End March of 2021 ?Started to feel tingling and numbness in her left hand.   July 2021. ?Went to see Primary Care Manager (PCM) at Facility, but was sent to ER because of high blood pressure related to lab coat fear (I am a retired, and during that time, we used the medical facility).  January 2022 established a new PCM (Not related to installation), because of increased left finger weakness. ?Difficulty holding clipper and clipping right fingernails ?Numbness, reduced dexterity, and mobility ?Referred to Electromyography (EMG) for carpal tunnel syndrome -prognosis negative (PCM suspected pinched nerve). Electromyography (EMG) measures muscle response or electrical activity in response to a nerve's stimulation of the muscle. The test is used to help detect neuromuscular abnormalities.  ?Referred to MRI for neck, and Physical Therapy ?No pinched nerve on MRI ?Physical Therapy had no effects, grip in hand weaker after 1 month   April 28, 2022. After visiting again with a new PCM because her left finger was getting weaker, suggested MRIs. ?MRI of the brain for Parkinson?s Disease -negative. ?MRI Brachial Plexus W/ & W/O Contrast -negative ?Referral to In-Network Neurologist   June 21, 2022. Visit with Dr (Neurologist) ?Blood work ordered ?EMG ordered   August 22, 2022. Visit with Dr for EMG ?Motor Nerve Conduction Studies completed ?Blood work ordered ?B12 High, Asialo-GM1 High    Late Sep 2022  ?left leg weakness and right finger tingling, numbness & weakness.   Mid Oct 2022  ?Slurred speeches on and off  ?Burning tingling sensation on my tongue   Late NOV 2022 Seen by Dr., -Medical Neurology ?EMG Ordered ?Invitae Genetic Testing ?Diagnosed with ALS   Mid-February 2023 Seen by Dr., for second opinion. ?EMG Ordered ?Invitae Genetic Testing ?Prevention Genetics Genetic Testing ?Diagnosed with ALS
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Confusional state, Contusion, Disorientation, Electroencephalogram normal
Clinical narrative: On 05/24/2022 pt. came home from work extremely confused and disoriented;  He was taken immediately to emergency room but by the time he was seen (7 hours later !) he was back to normal.  No tests were performed at the emergency room other than routine blood and urine tests which were all normal.  On September 21, 2023 pt. suffered a seizure during which he broke both arms and  his torso and face were bruised. His right shoulder required a reverse replacement.  He was placed on anti seizure medication. At a follow up appointment with neurologist, she reduced his dosage.   On April  23,2024 pt. suffered another seizure in which he broke his left arm again and is now awaiting reverse shoulder replacement for left.
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Laboratory test normal, Seizure, Shoulder arthroplasty, Upper limb fracture, Urine analysis normal
Clinical narrative: On 05/24/2022 pt. came home from work extremely confused and disoriented;  He was taken immediately to emergency room but by the time he was seen (7 hours later !) he was back to normal.  No tests were performed at the emergency room other than routine blood and urine tests which were all normal.  On September 21, 2023 pt. suffered a seizure during which he broke both arms and  his torso and face were bruised. His right shoulder required a reverse replacement.  He was placed on anti seizure medication. At a follow up appointment with neurologist, she reduced his dosage.   On April  23,2024 pt. suffered another seizure in which he broke his left arm again and is now awaiting reverse shoulder replacement for left.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Discomfort, Dizziness, Fatigue, Headache
Clinical narrative: Starting about 12 hours after the dose (915pm), I started having chills followed by fever then nausea and dizziness.  The chills went away after about an hour.  The fever symptoms went away after a couple hours.  The nausea was noticed in the morning upon awakening (600am) as well as dizziness.  I had to crouch down and rest because I was afraid I was going to faint and fall if I stood up for too long.  I was unable to go to work on Tuesday and had to call off sick.  Fatigue lasted for most all of the day (partly due to hardly being able to sleep because I was so uncomfortable).  I took 2 naps that day and still had the nausea and dizziness, and then the headaches started around 4:00pm that day and lasted for about 5 hours.  I recovered enough to come into work the following day.  After sleeping about 7 1/2 hours the only persisting symptoms were fatigue and some nausea.  Those have finally all gone away by the third day.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Impaired work ability, Nausea, Presyncope, Pyrexia, Sleep disorder
Clinical narrative: Starting about 12 hours after the dose (915pm), I started having chills followed by fever then nausea and dizziness.  The chills went away after about an hour.  The fever symptoms went away after a couple hours.  The nausea was noticed in the morning upon awakening (600am) as well as dizziness.  I had to crouch down and rest because I was afraid I was going to faint and fall if I stood up for too long.  I was unable to go to work on Tuesday and had to call off sick.  Fatigue lasted for most all of the day (partly due to hardly being able to sleep because I was so uncomfortable).  I took 2 naps that day and still had the nausea and dizziness, and then the headaches started around 4:00pm that day and lasted for about 5 hours.  I recovered enough to come into work the following day.  After sleeping about 7 1/2 hours the only persisting symptoms were fatigue and some nausea.  Those have finally all gone away by the third day.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine given was expired, no symptoms
Age: 49.0
Sex: F
Vaccine: PPV
Symptoms: Hypoaesthesia, Injection site erythema, Injection site swelling
Clinical narrative: Severe swelling and redness at the injection site, as well as numbness of the arm
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Rash
Clinical narrative: Vaccines administered at 11:30. Pt. advised to wait in waiting room x 15 min. At approximately 11:40 RN notified that patient developing a rash on face. Pt. returned to exam room and briefly assessed for any other symptoms. Pt. denied any other signs including shortness of breath and itching in throat. Pt. hooked up to pulse ox to monitor oxygen levels. Provider notified at onset of reaction. Provider gave verbal order for 25 mg diphenhydramine. 25 mg oral diphenhydramine administered at 11:42 am. Pt. monitored for 20 min following administration. Upon discharge pt. is stable, rash began to resolve and pt. denies any issues.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Erythema multiforme, Pyrexia, Rash
Clinical narrative: Fever of 102 beginning on 5/4/24.  Rash emerged on 5/6/24, spreading and worsening until taken to the doctor on 5/9/24.  Diagnosed with erythema multiforme on 5/9/24.
Age: 0.5
Sex: F
Vaccine: DTPPVHBHPB
Symptoms: Seizure
Clinical narrative: Several hours after 6 month vaccinations, had a seizure at bedtime lasting 15 minutes. Midazolam administered by EMS and taken to the emergency room. Patient had no fever.
Age: 13.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Dyspnoea, Eye swelling, Palpitations, Pruritus, Rash
Clinical narrative: Patient presented to our office after receiving vaccine complaining of problems breathing, itching, rash all over, eyes swelling and heart racing
Age: 49.0
Sex: F
Vaccine: DTAP
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse reactions noted. Patient was given an infanrix dtap when she was supposed to have been given a Tdap
Age: 8.0
Sex: M
Vaccine: MNQ
Symptoms: Unevaluable event
Clinical narrative: Vaccine given under unrecommend guidelines
Age: 11.0
Sex: M
Vaccine: TDAP
Symptoms: No adverse event, Wrong patient received product
Clinical narrative: During an outstation school clinic, the student was given an additional vaccine due to a name error.  Two students had the same first name and was misidentified by school staff and clinic staff.  Client should have only received a Hepatitis A vaccine but received a Tdap (Boostrix) as well. No adverse symptoms have been reported.
Age: 35.0
Sex: F
Vaccine: HPV9
Symptoms: Pain in extremity, Product administered at inappropriate site
Clinical narrative: PATIENT CLAIMED THE INJECTION SITE WAS TOO HIGH, HER ARM IS EXTREMELY HURT SINCE SHE RECEIVED THE VACCINE.
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Anxiety, Balance disorder, Chills, Dyspnoea, Feeling of body temperature change
Clinical narrative: Yesterday received Meningitis B vaccine/Bexsero. About 1 hour later had a 4 hour long "panic attack". After her vaccine, she went to the mall and starts to feel shaky, teeth chattering, and felt "stressed out". Sat down and took deep breaths. Then had really bad headache, noises made it worse, "pounding". Mom picked her up, and she was laying in the car shaking and "chattering". Then it felt like she couldn't breathe for 10 seconds, unsure why, did not choke on anything or feel SOB. Mom drove her to urgent care and they sat in parking lot to try and calm down. Never went into urgent care. Went home and was walking slowly, felt off balance, and still felt shaky. Dog startled her and she screamed. Started feeling hot/cold, was sweating profusely, did not check temperature. Laid down and did deep breaths. Awoke from nap drenched in sweat. Ate some soup and drank some soda and then went to bed for the night. Awoke this morning feeling a little better but still a little "anxious". Top portion of body feels warm, lower body feels colder. Headache mostly went away. Feeling a little better. Some residual body aches. No hives, eye swelling, SOB, or redness to the injection site.
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Headache, Hyperacusis, Hyperhidrosis, Nervousness, Pain
Clinical narrative: Yesterday received Meningitis B vaccine/Bexsero. About 1 hour later had a 4 hour long "panic attack". After her vaccine, she went to the mall and starts to feel shaky, teeth chattering, and felt "stressed out". Sat down and took deep breaths. Then had really bad headache, noises made it worse, "pounding". Mom picked her up, and she was laying in the car shaking and "chattering". Then it felt like she couldn't breathe for 10 seconds, unsure why, did not choke on anything or feel SOB. Mom drove her to urgent care and they sat in parking lot to try and calm down. Never went into urgent care. Went home and was walking slowly, felt off balance, and still felt shaky. Dog startled her and she screamed. Started feeling hot/cold, was sweating profusely, did not check temperature. Laid down and did deep breaths. Awoke from nap drenched in sweat. Ate some soup and drank some soda and then went to bed for the night. Awoke this morning feeling a little better but still a little "anxious". Top portion of body feels warm, lower body feels colder. Headache mostly went away. Feeling a little better. Some residual body aches. No hives, eye swelling, SOB, or redness to the injection site.
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Panic attack, Stress
Clinical narrative: Yesterday received Meningitis B vaccine/Bexsero. About 1 hour later had a 4 hour long "panic attack". After her vaccine, she went to the mall and starts to feel shaky, teeth chattering, and felt "stressed out". Sat down and took deep breaths. Then had really bad headache, noises made it worse, "pounding". Mom picked her up, and she was laying in the car shaking and "chattering". Then it felt like she couldn't breathe for 10 seconds, unsure why, did not choke on anything or feel SOB. Mom drove her to urgent care and they sat in parking lot to try and calm down. Never went into urgent care. Went home and was walking slowly, felt off balance, and still felt shaky. Dog startled her and she screamed. Started feeling hot/cold, was sweating profusely, did not check temperature. Laid down and did deep breaths. Awoke from nap drenched in sweat. Ate some soup and drank some soda and then went to bed for the night. Awoke this morning feeling a little better but still a little "anxious". Top portion of body feels warm, lower body feels colder. Headache mostly went away. Feeling a little better. Some residual body aches. No hives, eye swelling, SOB, or redness to the injection site.
Age: 1.25
Sex: F
Vaccine: DTAP, HEPA, HIBV
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient was given Dose of Hepatitis A too early. She already received first dose on 2/12/2024 at 12 months of age and received another dose in error on 4/29/2024. The patient did not have any adverse reaction and is aware she will have to come back for another dose 6 months from now.
Age: 58.0
Sex: M
Vaccine: VARZOS
Symptoms: Chest pain, Dizziness, Flank pain, Influenza virus test negative, Nausea
Clinical narrative: 2 days after vaccine given patient developed dizziness, N/V, chest and right sided soreness
Age: 58.0
Sex: M
Vaccine: VARZOS
Symptoms: SARS-CoV-2 test negative, Vomiting
Clinical narrative: 2 days after vaccine given patient developed dizziness, N/V, chest and right sided soreness
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthritis, Gait inability, Impaired work ability, Pain, Walking aid user
Clinical narrative: Extreme inflammation and all of my joints I couldn't walk for 3 months after receiving the injections I now use a cane and have a lot of difficulties always in extreme pain I can't get a job to support myself like this
Age: 0.08
Sex: M
Vaccine: HEPA
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient received Hepatitis A instead of Hepatitis B in error. Patient did not have any adverse reaction and is aware he will need correct dose of Hepatitis B next month.
Age: 12.0
Sex: M
Vaccine: HPV9, MNQ
Symptoms: Vomiting
Clinical narrative: Vomiting
Age: 0.83
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine given was expired, no symptom
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Flank pain, Lymphadenopathy, Mobility decreased, Pain in extremity
Clinical narrative: Lymph glands swelled under my arms to the point I could not put my arm down. Severe pain in arms and down my sides.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Chest X-ray abnormal, Cognitive disorder, Computerised tomogram head, Computerised tomogram neck
Clinical narrative: Hands became shaky during breakfast, could not feed self, thought a spoon was a straw.  Had a fall after running down the hall and sent to ER. Unremarkable CBC and CMP, received 500ml IV lactated Ringers in ER and returned to facility
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Differential white blood cell count normal, Fall, Full blood count normal, Loss of personal independence in daily activities, Lung disorder
Clinical narrative: Hands became shaky during breakfast, could not feed self, thought a spoon was a straw.  Had a fall after running down the hall and sent to ER. Unremarkable CBC and CMP, received 500ml IV lactated Ringers in ER and returned to facility
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic function test normal, Prothrombin time prolonged, Tremor
Clinical narrative: Hands became shaky during breakfast, could not feed self, thought a spoon was a straw.  Had a fall after running down the hall and sent to ER. Unremarkable CBC and CMP, received 500ml IV lactated Ringers in ER and returned to facility
Age: 16.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Blood glucose normal, Dizziness, Nausea, Pallor, Palpitations
Clinical narrative: At approximately 12:35 PM, when the patient and her mom were checking out, the patient complained of feeling dizzy, nauseous, and like her "heart was beating out of her chest".  Upon assessment, patient appeared pale and shaky.
Age: 16.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Tremor
Clinical narrative: At approximately 12:35 PM, when the patient and her mom were checking out, the patient complained of feeling dizzy, nauseous, and like her "heart was beating out of her chest".  Upon assessment, patient appeared pale and shaky.
Age: 53.0
Sex: M
Vaccine: MNQ
Symptoms: Erythema, Magnetic resonance imaging normal, Peripheral swelling
Clinical narrative: Patient came in and had  his left hand red and swollen through his finers. Doctor hAd started patient on keflex 500 and was ordered to have an mri on 05/07/24 to ensure to blood clots . Spoke to pt today at 2:20pm and he has no clots and he is on Vancomcycin 125mg 1 c tid and beandryl 25 mg 1 c po qid . His swelling is going down and being monitored by doctors. according to patient his swelling is completely gone
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, Tremor
Clinical narrative: Started to shake at diner table, Temp 97.4, pulse 101, SA02 94% on room air, (baseline in nonverbal), 1800 Temp 97.4, pulse 130, respirations 23, SA02 88-89% on Room air, still shaking, no pain. 1900 to Emergency room. ER gave tylenol and sent back to facility. Upon return to facility Temp 101.5, pulse 100, respirations 20, SA02 90% on Room Air.
Age: 51.0
Sex: M
Vaccine: VARZOS
Symptoms: Balance disorder, Chills, Dyspnoea, Headache, Hyperhidrosis
Clinical narrative: Called  clincal triage phone service @10:30 on 5/9.  cc - incapacitated  Started 12 hour after rec'ing Shingles vaccine (noon 5/7). HAs (4/10 but has  been worse and now getting worse), lethargy. Sweats/chills. Vertigo. Balance issues. Unable to drive (also taking care of mom who had  dementia).  Had f 102. Palpitations.   Took friend's oxycontin for HA (1 mg).  Had seemed improved in am compared with first day, but still feels 'waves'.  Feels a 'little' SOB. No stridor/hoarseness.   Drinking fluids and able to eat (no anorexia).   Pt says he called in part for public health reasons - alert clinic of potential SAE with shingle vaccine.
Age: 51.0
Sex: M
Vaccine: VARZOS
Symptoms: Impaired driving ability, Lethargy, Loss of personal independence in daily activities, Palpitations, Pyrexia
Clinical narrative: Called  clincal triage phone service @10:30 on 5/9.  cc - incapacitated  Started 12 hour after rec'ing Shingles vaccine (noon 5/7). HAs (4/10 but has  been worse and now getting worse), lethargy. Sweats/chills. Vertigo. Balance issues. Unable to drive (also taking care of mom who had  dementia).  Had f 102. Palpitations.   Took friend's oxycontin for HA (1 mg).  Had seemed improved in am compared with first day, but still feels 'waves'.  Feels a 'little' SOB. No stridor/hoarseness.   Drinking fluids and able to eat (no anorexia).   Pt says he called in part for public health reasons - alert clinic of potential SAE with shingle vaccine.
Age: 51.0
Sex: M
Vaccine: VARZOS
Symptoms: Vertigo
Clinical narrative: Called  clincal triage phone service @10:30 on 5/9.  cc - incapacitated  Started 12 hour after rec'ing Shingles vaccine (noon 5/7). HAs (4/10 but has  been worse and now getting worse), lethargy. Sweats/chills. Vertigo. Balance issues. Unable to drive (also taking care of mom who had  dementia).  Had f 102. Palpitations.   Took friend's oxycontin for HA (1 mg).  Had seemed improved in am compared with first day, but still feels 'waves'.  Feels a 'little' SOB. No stridor/hoarseness.   Drinking fluids and able to eat (no anorexia).   Pt says he called in part for public health reasons - alert clinic of potential SAE with shingle vaccine.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood glucose normal, Dyspnoea, Heart rate increased, Malaise
Clinical narrative: 5/8/24 awoke aching all over, weak, decrease in function as unable to sit up in bed independantly,  Felt sick all over, Temp 100.7, pulse 107, respirations 24-28, b/p 77/47, SA02 90% on room air, alert and oriented X 2, blood glucose 118, respirations labored, sent to ER, admitted
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Pain
Clinical narrative: 5/8/24 awoke aching all over, weak, decrease in function as unable to sit up in bed independantly,  Felt sick all over, Temp 100.7, pulse 107, respirations 24-28, b/p 77/47, SA02 90% on room air, alert and oriented X 2, blood glucose 118, respirations labored, sent to ER, admitted
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HEP
Symptoms: Extra dose administered, No adverse event
Clinical narrative: CHILD RECEIVED TWO HEP B VACCINES ON SAME DAY; NO ADVERSE SYMPTOMS AT TIME OF ADMINISTRATION. CONTACTED GSK MANUFACTURER WHO STATED CDC GUIDELINES STATE NO ADVERSE OUTCOMES FOR RECEIVING TWO DOSES OF HEP B ON SAME DAY.
Age: 60.0
Sex: M
Vaccine: HEP
Symptoms: Underdose
Clinical narrative: 60 year old pt was given a pediatric Hep B vaccination
Age: 16.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Product administered to patient of inappropriate age, Underdose, Wrong product administered
Clinical narrative: 10:40 am COVID vaccine for 6m through 11y (Pediatric dose) was given erroneously (patient is 16 years old). Per CDC recommendations patient can receive another dose of the same vaccine today. Patient's mother's contact phone number was called and a message requesting a call-back was left. Mother returned my call and agreed to bring the patient back to complete the dose. 1:45 pm Patient returned, 2nd Pediatric dose of COVID vaccine administered. Patient tolerated well. No adverse reaction observed.
Age: 0.25
Sex: F
Vaccine: RV5
Symptoms: Gastrointestinal pathogen panel, Intussusception, Occult blood, Urine analysis
Clinical narrative: Patient was admitted with intussusception
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Allergy to vaccine, Blood test normal, Laboratory test normal, Urticaria
Clinical narrative: He got his vaccine, had hives, he is allergic to cologne, perfumes, etc., cold drinks and broke out with the hives all over his body.  He gets allergy shots once a month, every 28 days.  He has been in and out of the hospital since then for the same thing.  He was told that he had an allergic to the vaccine itself.  He has been given was Xolair 150 mg 2 doses every 28 days, he has used many creams and other treatments and nothing it working.  He did not have any issues with skin problems prior to the vaccine.  He did have blood work and tests done which did not reveal anything.
Age: 45.0
Sex: F
Vaccine: HPV9
Symptoms: Thrombosis
Clinical narrative: Patient's daughter called stating that her mother was hospitalized this past weekend for a blood clot. Per daughter, the doctor stated that one of the reasons for the blood clots could have possibly been that she got a vaccine and that the immunizer may have hit a vein. Per the immunizer, the area did not bleed and there were no signs of hitting the vein at the time of the event. Patient daughter insisted that the vaccine is the specific reason for the blood clot patient was hospitalized for.  When tried calling daughter back for more specific information (days in hospital, if recovered, etc.), she did not answer.
Age: 11.0
Sex: M
Vaccine: COVID19, DT, HPV9, MNQ
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient was given TD vaccine and was not due for just TD. Pt. was due for a Tdap per CDC guidelines Pt is not covered for pertussis and  will need to return for Tdap. No reactions reported at this time parent was called immediately  and agrees to return for tdap
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Oedema peripheral, Swelling, Swelling face
Clinical narrative: face, neck, armpit swelling and bruising
Age: 81.0
Sex: F
Vaccine: RSV
Symptoms: C-reactive protein increased, Erythema, Full blood count, Joint swelling, Mobility decreased
Clinical narrative: Pain, swelling, redness of arm within 4 hours of getting injection. Swelling was entire shoulder joint area, posteriorly on back of arm/shoulder as well as into upper arm.  She was unable to move/lift her arm
Age: 81.0
Sex: F
Vaccine: RSV
Symptoms: Pain in extremity, Peripheral swelling, Red blood cell sedimentation rate
Clinical narrative: Pain, swelling, redness of arm within 4 hours of getting injection. Swelling was entire shoulder joint area, posteriorly on back of arm/shoulder as well as into upper arm.  She was unable to move/lift her arm
Age: 40.0
Sex: F
Vaccine: RAB
Symptoms: Expired product administered
Clinical narrative: NONE PER PT. FILING THIS REPORT AS VACCINE LOT 5683MF012 EXPIRED ON 4-30-2024
Age: 54.0
Sex: M
Vaccine: VARZOS
Symptoms: No adverse event
Clinical narrative: no adverse event reported need to do this report because vaccines was given to a pt under 60 yrs old
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: NONE KNOWN. REPORT IS BEING FILED SINCE LOT 5683MF012 EXPIRED ON 4-30-2024 ACCORDING TOTHE NOVAVAX WEBSITE AND PT GOT THIS VACCINE ON 5-3-2024
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: NONE KNOWN FILING REPORT SINCE LOT 5683MF012 NOVAVAX EXPIRED ON 4-30-2024 AND PT GOT VACCINE ON 5-3-2024
Age: 0.75
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Expired product administered
Clinical narrative: Patient received vaccine on 3/18 that had expired on 2/17. Patient returned for revaccination.
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Fall, Muscular weakness
Clinical narrative: Resident received COVID vaccine on 5/7/2024 a.m.  On 5/8/2024 at approximately 4:15 p.m., resident fell to her knees while ambulating. Resident reported "my legs just got weak." Resident had no obvious signs of injury and reported no other symptoms.
Age: 85.0
Sex: F
Vaccine: RSV
Symptoms: Extra dose administered
Clinical narrative: Patient had already gotten a dose of the Arexvy RSV vaccine at our pharmacy on 9/12/23 and then we administered another RSV vaccine (Abrysvo) to same patient on 12/13/23. This should not have been given on 12/13/23. RSV is only a one dose vaccine at this time.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Skin warm, Swelling
Clinical narrative: Red bump about 1 cm at the highest and 4cm in diameter. Appeared after 24+ hours. Warm and sore but not itchy
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product label confusion
Clinical narrative: expiration date written on box and vaccine syringe is in the order of yyyy-mm-dd . No adverse reactions noted or reported by patient.
Age: 24.0
Sex: F
Vaccine: HEP, HEPA, PNC20, TDAP
Symptoms: Dizziness, Immediate post-injection reaction, Vomiting
Clinical narrative: Patient was feeling lightheaded right after getting vaccines.2 minutes later she threw up.Patient claimed she was feeling way better after throwing up.No other side effects or reactions after.
Age: 29.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Rash, Rash erythematous
Clinical narrative: Patient experienced a 2.5' x 1.5" raised area and redness at the site of the injection, along with raised red bumps that spread about 4" down starting at the suprasternal notch across the top front of her chest bilaterally and some on her chin. This same rash was at the base of her neck on the top of her back.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product label confusion
Clinical narrative: Vaccine expired. Expiration date written on box and vaccine syringe is in the order of yyyy-mm-dd. No adverse reactions noted or reported by patient.
Age: 15.0
Sex: M
Vaccine: PPV
Symptoms: Pyrexia
Clinical narrative: Fever of 103.4 began four hours after the vaccination.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Medical Assistant reported inadvertently administering an expired dose of MMRII to a patient.; This spontaneous report has been received from a medical assistant and refers to a 12-month-old female patient. There was no information regarding the patient's medical history, concurrent conditions and concomitant medications provided.   On 10-APR-2024, the patient was inadvertently vaccinated with expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin [rHA]) (M-M-R II) injection, dose number: first, administered in the right thigh, lot #W023071 confirmed to be valid with expiration date: 05-APR-2024 (exact dose and route of administration were not reported), for prophylaxis (Expired product administered). The vaccine operator was a trained healthcare professional (medical assistant). The vaccine did not undergo any temperature excursions and was supported per Post Expiry Memo. No prescription drug treatment was required. There was no product quality complaint. The event was reported to a physician and manufacturer. No additional adverse event was reported (No adverse event).
Sex: F
Vaccine: PNC, PPV
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Product name confusion
Clinical narrative: got a little swollen and it was itchy; only a small red mark that got a little swollen and it was itchy.; got a little swollen and it was itchy; Unknown vaccine product administered; administered with PREVNAR 23, but I later found out that PREVNAR doesn't have 23 serotypes. Did they mix up the names; This spontaneous report was received from a nurse practitioner and referred to herself with unknown age. The patient's concurrent conditions, concomitant therapies, historical drugs and historical conditions were not reported.  On an unknown date, the patient started therapy with pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) injection, administered intramuscularly (strength, dose, lot #, anatomical site of administration and expiry date were not provided) or pneumococcal vaccine conj 7v (crm197) (PREVNAR), administered intramuscularly for pneumococcal vaccination (strength, formulation, dose, lot #, anatomical site of administration and expiry date were not provided).  The reported stated the pharmacy told she was administered with "PREVNAR 23", but she later found out that pneumococcal vaccine conj 7v (crm197) (PREVNAR) didn't have 23 serotypes, the reporter wondered if they mixed up the names or if there a difference in the vaccines (product name confusion). She saw that pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) had the 23 serotypes, but they didn't tell her exactly what vaccine she was given (unknown vaccine product administered). On an unknown date, she had reaction (small red mark that got a little swollen and it was itchy) to the vaccine after it was administered. She took some diphenhydramine hydrochloride (BENADRYL) for the itching and it cleared up really quickly (resolved). The action taken with pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) regarding got a little swollen and it was itchy was reported as not applicable. The action taken with pneumococcal vaccine conj 7v (crm197) (PREVNAR) was not applicable. The reporter considered reaction (small red mark that got a little swollen and it was itchy) to be related to pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) or pneumococcal vaccine conj 7v (crm197) (PREVNAR).
Age: 6.0
Sex: U
Vaccine: MMRV
Symptoms: Expired product administered, No adverse event
Clinical narrative: Confirmed no symptoms or side effects reported and no temperature excursion history on PROQUAD; Medical Assistant called to report that a dose of PROQUAD that expired on 4/24/2024, was administered yesterday, 4/29/2024 to an patient from country.; This spontaneous report was received from a medical assistant concerning to a 6-year-old patient of unspecified gender (reported as an patient from country).   The patient's medical history, historical drugs, known allergies, concurrent conditions, and concomitant therapies were not reported. Their  historical vaccinations included Measles, Mumps, and Rubella vaccine (MMR), Varicella vaccine, and measles and Rubella (MR) vaccine.   On 29-APR-2024, the patient  was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) injection, lot #W034210, expiration date: 24-APR-2024, administered for prophylaxis (strength, dose, anatomical location, and route of administration were not provided). Confirmed no symptoms or side effects reported and no temperature excursion history on this suspect vaccine (expired product administered). measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) dose was supported by the Post Expiry Memo.
Sex: F
Vaccine: HPV9
Symptoms: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling
Clinical narrative: injection site became itchy, red and swollen and a hard visible bump; injection site became itchy, red and swollen and a hard visible bump; injection site became itchy, red and swollen and a hard visible bump; injection site became itchy, red and swollen and a hard visible bump; This spontaneous report was received from medical assistant and referred to a female patient of unknown age.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 01-APR-2024, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (strength, dose, lot #, expiry date, and route of administration were not provided). The patient experienced no symptoms. On 01-MAY-2024, the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (strength, dose, lot #, expiry date, and route of administration were not provided).   On the same day, the patient experienced injection site itchy, red and swollen and a hard visible bump the size of half a dollar. The patient was treated for the events with ibuprofen, diphenhydramine (BENADRYL) and applied ice at home. At the time of reporting, the outcome of the events was unknown.    The causal relationship between the events and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was unknown.   Lot number is being requested and will be submitted if received.
Sex: U
Vaccine: HEP
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE reported.; after a temperature excursion to patient; This spontaneous report was received from medical assistant and refers to an unknown age and gender patient. Pertinent medical history, concomitant medications and drug reactions/allergies were not reported.  On 15-APR-2024, the patient received once dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) intramuscular injection, once, lot #X006977, expiration date: 01-OCT-2025, administered for prophylaxis (strength, dose and route of administration were not provided) after a temperature excursion for 39.2 degree F for 3 hours 18 minutes (Product storage error). There was no previous temperature excursion. No additional event was reported (no adverse event).   This is one of several reports from the same reporter.  ; Sender's Comments:  US-009507513-2405USA001088: US-009507513-2405USA000970: US-009507513-2405USA001261:2405USA001190 US-009507513-2405USA001251:2405USA001190
Sex: U
Vaccine: RV5
Symptoms: No adverse event, Product storage error
Clinical narrative: no additional AE reported; Medical assistant reported ROTATEQ was administered after a temperature excursion to patient; This spontaneous report has been received from a medical assistant, referring to a patient of unknown age and gender. The information regarding the patient's concurrent conditions, concomitant therapies or medical history was not reported.  On 16-APR-2024, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) at a dose of 1 dosage form, lot# 1968392, expiry date 24-MAY-2024, for prophylaxis (route of administration and anatomical location were not reported). The vaccine underwent temperature excursion prior to administration (3 hours 18 minutes in 32.9 F) (product storage error). The vaccine had no previous temperature excursions. No additional adverse event reported (no adverse event).  This is one of 33 reports received from the same reporter.; Sender's Comments:  US-009507513-2405USA001244:2405USA001244 US-009507513-2405USA001031:2405USA001031 US-009507513-2405USA001055:2405USA001055 US-009507513-2405USA001064:2405USA001064 US-009507513-2405USA001230:2405USA001230 US-009507513-2405USA000948:2405USA000948 US-009507513-2405USA001143:2405USA001143 US-009507513-2405USA001146:2405USA001146 US-009507513-2405USA000978:2405USA000978 US-009507513-2405USA001237:2405USA001237 US-009507513-2405USA001226:2405USA001226 US-009507513-2405USA000864:2405USA000864 US-009507513-2405USA001264:2405USA001264 US-009507513-2405USA001249:2405USA001249 US-009507513-2405USA000970:2405USA000970 US-009507513-2405USA001261:2405USA001261 US-009507513-2405USA001217:2405USA001217 US-009507513-2405USA001240:2405USA001240 US-009507513-2405USA001152:2405USA001152 US-009507513-2405USA001167:2405USA001167 US-009507513-2405USA001190:2405USA001190 US-009507513-2405USA001156:2405USA001156 US-009507513-2405USA001186:2405USA001186 US-009507513-2405USA001192:2405USA001192 US-009507513-2405USA001173:2405USA001173 US-009507513-2405USA000954:2405USA000954 US-009507513-2405USA001151:2405USA001151 US-009507513-2405USA001159:2405USA001159 US-009507513-2405USA001172:2405USA001172
Sex: U
Vaccine: RV5
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE reported.; Medical assistant reported ROTATEQ was administered after a temperature excursion to patient; This spontaneous report has been received from a medical assistant, referring to a patient of unknown age and gender. The information regarding the patient's concurrent conditions, concomitant therapies or medical history was not reported.  On 23-APR-2024, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) at a dose of 1 dosage form, lot# 1968392, expiry date 24-MAY-2024, for prophylaxis (route of administration and anatomical location were not reported). The vaccine underwent temperature excursion prior to administration (3 hours 18 minutes in 32.9 F) (product storage error). The vaccine had no previous temperature excursions. No additional adverse event reported (no adverse event).  This is one of 33 reports received from the same reporter.; Sender's Comments:  US-009507513-2405USA001251:2405USA001261 US-009507513-2405USA001244:2405USA001244 US-009507513-2405USA001031:2405USA001031 US-009507513-2405USA001055:2405USA001055 US-009507513-2405USA001064:2405USA001064 US-009507513-2405USA001230:2405USA001230 US-009507513-2405USA000948:2405USA000948 US-009507513-2405USA001143:2405USA001143 US-009507513-2405USA001146:2405USA001146 US-009507513-2405USA000978:2405USA000978 US-009507513-2405USA001237:2405USA001237 US-009507513-2405USA001226:2405USA001226 US-009507513-2405USA000864:2405USA000864 US-009507513-2405USA001264:2405USA001264 US-009507513-2405USA001249:2405USA001249 US-009507513-2405USA000970:2405USA000970 US-009507513-2405USA001217:2405USA001217 US-009507513-2405USA001240:2405USA001240 US-009507513-2405USA001152:2405USA001152 US-009507513-2405USA001167:2405USA001167 US-009507513-2405USA001190:2405USA001190 US-009507513-2405USA001156:2405USA001156 US-009507513-2405USA001186:2405USA001186 US-009507513-2405USA001192:2405USA001192 US-009507513-2405USA001173:2405USA001173 US-009507513-2405USA000954:2405USA000954 US-009507513-2405USA001151:2405USA001151 US-009507513-2405USA001159:2405USA001159 US-009507513-2405USA001172:2405USA001172
Age: 12.0
Sex: U
Vaccine: HPV9
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AE; Caller reported AE on behalf of a patient who received expired dose of GARDASIL 9 on 5/1/2024 (w/ no TEs)-- SUPPORTED via postexpiry; This spontaneous report was received from Consumer and refers to a 12-year-old patient of an unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 01-MAY-2024, the patient was vaccinated with expired dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 0.5 milliliter, valid lot #U029033 with expiration date: 13-MAR-2024, administered for prophylaxis (strength, and route of administration were not provided) (expired product administered). No symptoms were reported reported. No additional adverse event (AE) was reported.
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE; Medical assistant called to report an excursion.; This spontaneous report was received from a medical assistant, referring to a patient of unknown gender and age. The patient's medical history, concurrent condition and concomitant therapies were not reported.  On 04-APR-2024, the patient was administered of measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live, recombinant Human albumin (rHA) (PROQUAD) injection, lot # W036940 has been verified to be a valid lot number, expiration date  reported and validated as 19-MAY-2025 for prophylaxis (strength, dose, frequency, and route of administration were not provided), after undergoing a temperature excursion (product storage error). Temperature excursion was as following: the vaccine was stored under 7.9 Fahrenheit (F)/6 F up to 14 F for 38 minutes. Previous temperature excursion included 6.3 F / 6 F to 14 F for 13 hours. No additional adverse event (AE)/ product quality concern (PQC) was reported (no adverse event).  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2404USA007180:
Sex: U
Vaccine: MMR, VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE; Medical assistant called to report an excursion.; This spontaneous report was received from a medical assistant, referring to a patient of unknown gender and age. The patient's medical history, concurrent condition and concomitant therapies were not reported.  On 05-APR-2024, the patient was administered of measles, mumps, and rubella (Wistar Ra 27-3) virus vaccine, live, recombinant Human albumin (rHA) (M-M-R II) injection, lot # W019422 has been verified to be a valid lot number, expiration date reported and validated as 20-JUN-2024 for prophylaxis (strength, dose, frequency, and route of administration were not provided) and varicella virus vaccine live (Oka/Merck) (VARIVAX) injection, lot # X017486 has been verified to be a valid lot number, expiration date reported and validated as 25-JUN-2025 for prophylaxis (strength, dose, frequency, and route of administration were not provided), after undergoing a temperature excursion (product storage error). Temperature excursion was as following: the vaccine was stored under 7.9 Fahrenheit (F)/6 F up to 14 F for 38 minutes. Previous temperature excursion included 6.3 F / 6 F to 14 F for 13 hours. No additional adverse event (AE)/ product quality concern (PQC) was reported (no adverse event).  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2404USA007180:
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE; Medical assistant called to report an excursion.; This spontaneous report was received from a medical assistant, referring to a patient of unknown gender and age. The patient's medical history, concurrent condition and concomitant therapies were not reported.  On 05-APR-2024, the patient was administered of measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live, recombinant Human albumin (rHA) (PROQUAD) injection, lot # X018732 has been verified to be a valid lot number, expiration date was reported as 26-DEC-2024 and upon internal validation established as 06-JAN-2025 for prophylaxis (strength, dose, frequency, and route of administration were not provided), after undergoing a temperature excursion (product storage error). Temperature excursion was as following: the vaccine was stored under 7.9 Fahrenheit (F)/6 F up to 14 F for 38 minutes. Previous temperature excursion included 6.3 F / 6 F to 14 F for 13 hours. No additional adverse event (AE)/ product quality concern (PQC) was reported (no adverse event).  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2404USA007180:
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE; Medical assistant called to report an excursion.; This spontaneous report was received from a medical assistant, referring to a patient of unknown gender and age. The patient's medical history, concurrent condition and concomitant therapies were not reported.  On 06-APR-2024, the patient was administered of measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live, recombinant Human albumin (rHA) (PROQUAD) injection, lot # X018732 has been verified to be a valid lot number, expiration date  reported as 26-DEC-2024 and upon internal validation established as 06-JAN-2025 for prophylaxis (strength, dose, frequency, and route of administration were not provided), after undergoing a temperature excursion (product storage error). Temperature excursion was as following: the vaccine was stored under 7.9 Fahrenheit (F)/6 F up to 14 F for 38 minutes. Previous temperature excursion included 6.3 F / 6 F to 14 F for 13 hours. No additional adverse event (AE)/ product quality concern (PQC) was reported (no adverse event).  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2404USA007180: